Latest Biotech News

Eli Lilly disclosed additional safety and tolerability data for retatrutide at the American Diabetes Association meeting, including counts of arrhythmias and major cardiovascular complications...

Roche plans to initiate a Phase 2 trial combining petrelintide and enicepatide later this year, according to ADA26 reporting. The companies are positioning the dual-incretin approach as a path to...

Pfizer presented updated clinical data supporting monthly dosing of berobenatide for obesity, following earlier signals from VESPER-3. In the study, patients transitioned from weekly dosing to...

At ADA26, Pfizer added additional framing for berobenatide’s use in obesity and diabetes, citing data presented alongside its long-acting GLP-1 receptor agonist program. The coverage also ties the...

Ona secured an $86.6 million venture round positioned among Spain’s largest biotech financings, according to Biocentury Finance reporting. The capital injection underscores continued appetite for...

Forbion announced the hire of John McDonald as an operating partner focused on business development and M&A, with prior experience including corporate business development leadership at Novo...

An early first-in-human study is underway for ABBV-706, a SEZ6-targeting antibody-drug conjugate (ADC), in patients with advanced solid tumors. The program’s Journal of Clinical Oncology...

SYS6043, a B7-H3/Top1 antibody-drug conjugate (ADC), began Phase 1 dose escalation in solid tumor malignancies, according to the study listing. The start of dose escalation highlights ongoing...

Researchers engineered a portable CRISPR-based assay for mpox detection in the wake of the 2025 outbreak in Sierra Leone, as described in the report. The approach is aimed at field diagnostics and...

Eli Lilly disclosed additional safety and tolerability data for retatrutide at the American Diabetes Association meeting and in The Lancet, extending results from TRANSCEND-T2D-1. The company...

Pfizer reinforced its obesity and diabetes case for berobenatide with new mid-stage results presented at ADA and reported by STAT+. In the VESPER-3 study, patients transitioned from weekly dosing...

The World Health Organization unveiled a six-month plan to stamp out the current Bundibugyo Ebola virus outbreak in Africa, including a major scale-up of point-of-care molecular diagnostics. WHO...

Roche said it will start a Phase 2 trial combining petrelintide and enicepatide this year, targeting obesity with an eye toward differentiating safety and efficacy across its amylin-based program....

Antibody–drug conjugates headlined first-in-human development at ASCO, according to BioCentury’s analysis of 137 FIH studies highlighted at the meeting. The review found that ADCs accounted for...

A Cell study led by Gabriel D. Victora at The Rockefeller University tracked thousands of B cells across more than 100 germinal centers in mice and found the process of affinity improvement is far...

Researchers in Cell Death Discovery reported that the transcription factor MSX1 plays a tumor-promoting role in cervical cancer. The study, published June 5, 2026, described new molecular...

A study in preclinical Alzheimer’s research reported that microglial CD31 hinders amyloid-beta clearance and worsens pathology in a 5×FAD mouse model. The work identified CD31 as a critical...

Fulcrum Therapeutics said it is laying off 85% of staff after discontinuing development of its lead sickle cell disease candidate, citing an FDA decision that left “no viable regulatory path.” The...

Medable launched an Agentic Accelerator Program to help life sciences companies deploy agentic AI across clinical development. The offering includes onboarding, integration support, governance,...

Eli Lilly reported additional safety and tolerability data for retatrutide, its next-generation obesity drug, in disclosures tied to the TRANSCEND-T2D-1 late-stage program. At the American...